Pollen counts are soaring across the US - making allergy symptoms worse each year

Pollen counts have been rising in several states across the US, including Illinois, North Carolina and Tennessee, and experts say that warmer weather from climate change could be to blame.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

The U.S. Food and Drug Administration has approved Merck&Co Inc's cancer therapy Keytruda (pembrolizumab) as part of a combination therapy for previously untreated patients with the most common type of kidney cancer, the company said on Monday.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
Conclusion In conclusion, this study wants to stress the importance of early diagnosis. As in the majority of primary immunodeficiency diseases, the prognosis of LAD3 is extremely dependent on early age diagnosis, with timely management of bacterial infections and consideration for HSCT. In addition, this autosomal recessive disorder has high incidence in areas with high rate of consanguineous marriages. Therefore, broadening the spectrum of known mutations underlying the phenotype of such a life-threatening disease can help offering and performing better genetic counseling and prenatal diagnosis. Ethics Statement This ...
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research
Conclusions World population is aging and the increase in life expectancy is often unhealthy. In particular, musculoskeletal aging, which leads to sarcopenia and osteoporosis, has several causes such as changes in body composition, inflammation, and hormonal imbalance. Sarcopenia, osteoporosis, and more frequently, sarcopenic obesity are commonly associated with aging and frequently closely linked each other, often leading to the development of a frailty syndrome. Frailty syndrome favors an increased risk of loss function in daily activities, for cardiovascular diseases, cancers, falls, and mortality. As the number of eld...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
This article is licensed under aCreative Commons Attribution-NonCommercial 3.0 Unported Licence.Mario Rothbauer, Verena Charwat, Barbara E.M. Bachmann, Drago Sticker, Richard Novak, Heinz Dieter Wanzenboeck, Richard A. Mathies, Peter Ertl Microfluidic study of transient cell-to-cell interaction cascades as a response to circulating factors during Type 1 allergic reactions are still in its infancy. Here, we report a fully-automated, miniaturized and... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Lab Chip latest articles - Category: Chemistry Authors: Source Type: research
TUESDAY, April 23, 2019 -- Even though asthma is common in the United States, there are many misconceptions about the respiratory disease, an allergy/immunology expert says. " Asthma is a serious condition that affects more than 26 million Americans...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Vickery BP, Vereda A, Casale TB, Beyer K, du Toit G, Hourihane JO, et al. AR101 Oral Immunotherapy for Peanut Allergy. N Engl J Med 2018;379:1991-2001.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Current Best Evidence Source Type: research
Conditions:   Enterobacteriaceae Infections;   Community-Acquired Infections;   Healthcare Associated Infection Intervention:   Sponsors:   University of North Carolina, Chapel Hill;   National Institute of Allergy and Infectious Diseases (NIAID) Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Anxiety Disorders;   Generalized Anxiety Disorder Interventions:   Drug: Escitalopram;   Other: Placebo Sponsor:   Allergan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Enterobacteriaceae Infections;   Community-Acquired Infections;   Healthcare Associated Infection Intervention:   Sponsors:   University of North Carolina, Chapel Hill;   National Institute of Allergy and Infectious Diseases (NIAID) Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Anxiety Disorders;   Generalized Anxiety Disorder Interventions:   Drug: Escitalopram;   Other: Placebo Sponsor:   Allergan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Health